Brevundimonas diminuta is rarely associated with invasive infections. We report the case of a previously healthy young man with pleural effusion, in which B. diminuta was recovered but incorrectly identified as Kingella kingae when it was freshly isolated. Consequently, the misidentification resulted in initial treatment failure. The correct identification was achieved through further incubation, sequencing of the 16S rRNA gene and MS.
Introduction
Brevundimonas (formerly referred to as Pseudomonas) are aerobic, non-spore-forming, Gram-negative bacilli. They are straight or slightly curved, 1 to 5 mm in length, 0.5 to 1.0 mm in width, and mostly positive for catalase and oxidase. Brevundimonas human infections are generally caused by Brevundimonas vesicularis, and only a few cases of severe opportunistic infections, particularly in patients with immunocompromised diseases, have been reported for Brevundimonas. diminuta (Chi et al., 2004; Han & Andrade, 2005; Lee et al., 2011; Menuet et al., 2008) . In the case presented here, B. diminuta was recovered in a healthy young male without serious underlying diseases. To the best of our knowledge, this is the first case report of B. diminuta detected in the pleural fluid as a cause of community-acquired infective pleurisy.
Case report
A 38-year-old man had a history of intermittent cough, sore throat, breath holding and fever over a 2 week period. To relieve the symptoms, he had taken azithromycin orally once daily (500 mg per day) for 3 days in a community hospital, but it was ineffective. Afterwards, he was admitted to the Civil Aviation General Hospital on December 13 2011. On examination, the patient was febrile (38.9 u C), with a respiratory rate of 22 breaths min
21
, a pulse rate of 91 beats min 21 and blood pressure of 120/90 mmHg. Physical examination showed that he was a well-nourished man in mild distress due to chest pain and tightness. He had a decreased range of motion of the left side of his chest, and his breath sound was significantly reduced by auscultation over the left diseased side. Cardiovascular and abdominal examinations were unremarkable. In addition, history taking revealed that he was a heavy smoker for about 10 years, and had no surgical history and co-morbid diseases.
On admission, his peripheral leukocyte count was 9090 mm 23 with 81.2 % neutrophils; other relevant laboratory findings included a platelet count of 228 000 platelets mm 23 and an elevated C-reactive protein level of 21.6 mg l 21 (reference range 0-3.0 mg l
). Ultrasonography of the abdomen showed a mild diffuse fatty liver. A large left-sided pleural effusion was seen on a chest computed tomography scan. Screening tests for human immunodeficiency virus, hepatitis B virus and hepatitis C virus infections were non-reactive, and no abnormalities in liver or renal function tests were found. The pleural fluid was collected via drainage and sent to our laboratory for chemical analysis, Gram staining, anaerobic and aerobic culture, and detection of Mycobacterium tuberculosis by acid-fast staining as well as real-time PCR. Direct Gram staining of the sample revealed polymorphonuclear leukocytes [5-10 cells per low power field ( 6100 magnification)] and a few Gram-negative bacilli [0-2 bacilli per high power field ( 61000 magnification oil immersion)]. After 24 h incubation at 35.0 u C, colonies grew rather slowly on 5 % sheep blood agar and chocolate agar, and were slightly yellow in colour. No colonies grew on the MacConkey agar and in anaerobic culture. The isolates were later identified as Kingella kingae (97% of identity) by the Phoenix automated microbiology system negative identification (NID) panel (Becton Dickinson Diagnostic Systems). The adenosine deaminase level in pleural fluid was 26.6 IU l 21 (reference range 0-35 IU l 21 ). The realtime PCR [using a commercial diagnostic kit with the lowest detection limit of 10 copies (ml M. tuberculosis culture)
, provided by Qiagen and processed on a LightCycler 480 real-time PCR system] and acid-fast staining of M. tuberculosis were negative for the pleural fluid. No tumour cells were found by pathological examination. Analyses of sputum specimen and blood culture (BACT/ ALERT 3D; bioMérieux) were also conducted, but the results were negative for growth.
The patient was initially started on intravenous ciprofloxacin (400 mg every 12 h) as an empirical antibiotic treatment. Antibiotic susceptibility tests (ASTs) were not performed because of the lack of Clinical and Laboratory Standards Institute (CLSI) approved standards for K. kingae. On the basis of the known susceptibility of K. kingae to ciprofloxacin (Yagupsky et al., 2001) , the treatment program was continued. The second pleural fluid sample was collected 2 days after the first one, and after 24 h of incubation its culture yielded the same organism, which was shown to be K. kingae by the Phoenix system again. The related laboratory parameters remained nearly unchanged. The patient felt obvious alleviation of pain after drainage but his fever remained high (.38.5 u C) after 7 days of hospitalization following admission. Therefore, he was transferred to the Beijing Specialized Chest Hospital (no. 97 Ma Chang, Tongzhou District, Beijing, PR China) for further treatment. Afterwards, no drainage was conducted due to the low amount of pleural fluid. A series of tests for M. tuberculosis, including T-SPOT.TB test (Oxford Immunotec) and antibody test, were carried out, but were still negative. For the pulmonary infection and infectious pleuritis suspected according to the previous examinations, and because Gram-negative bacilli had been detected previously in the pleural fluid and fluoroquinolones were ineffective, the antibiotic therapy was switched to intravenous piperacillin/tazobactam (4 g/ 500 mg every 8 h). The patient defervesced over the first 48 h, and after 7 days he was clinically well and discharged. No recurrence of symptoms and signs was reported in 1 month of outpatient follow-up.
The organism was suspected of being wrongly identified in our hospital, and so supplementary tests were conducted. The organism was positive for catalase and oxidase, different from the characteristics of K. kingae, which is negative for catalase, though positive for oxidase (Menuet et al., 2008; Roiz et al., 1997) . Interestingly, in the later confirmatory test, when the same strain was initially incubated at 35 uC for the 24 h before loading into the Phoenix system, it was incorrectly identified as K. kingae (confidence level 97 %), but after further incubation for another 24 h to make the isolates grow fully, the identification changed to B. diminuta (confidence level 99 %). To clarify why the misidentification occurred, we reviewed the results from the Phoenix system testing and found that the following biochemical results had changed from negative to positive when the incubation duration was extended to 48 h: glutaryl-glycine-arginine-7-amino-4-methylcoumarin, glycine-proline-7-amino-4-methylcoumarin, polymyxin B, citrate, a-ketoglutaric acid, malonate and D-mannitol. The expected results of the first three tests were positive for B. diminuta but negative for K. kingae, which were critical tests for differentiating B. diminuta from K. kingae, and might be the underlying reason for our original misidentification. As the biochemical identification system produced indeterminate results, the organism was transferred to a reference laboratory (Department of Clinical Laboratory, Beijing Tongren Hospital, Capital Medical Univerisity, Beijing, PR China) to be analysed by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS; Bruker Daltonics) and was identified as B. diminuta. Afterwards, the sequence analysis of a 730 bp segment of the 16S rRNA genes (forward primer 59-AGTTTGATCTGGCTCAG-39 and reverse primer 59-GGACTACGAGGTATCTAAT-39) of the organism demonstrated 99.1 % identity with B. diminuta (GenBank accession no. NR_040805.1).
ASTs were performed using the Kirby-Bauer disc-diffusion method on Mueller-Hinton agar and automatic microdiffusion by the Phoenix system, and interpreted according to the breakpoints set for Pseudomonas aeruginosa and non-Enterobacteriaceae by the Clinical and Laboratory Standards Institute as suggested in a previous report (Han & Andrade, 2005) . The isolates were susceptible to piperacillin, amikacin, meropenem, tetracycline, chloramphenicol, gentamicin, piperacillin/tazobactam, imipenem and cefoperazone/sulbactam, and resistant to ceftazidime, cefepime, aztreonam, levofloxacin, ciprofloxacin and trimethoprim/sulfamethoxazole, as shown in Table 1 .
Discussion
B. diminuta is a rare human pathogen isolated from clinical specimens in patients, most of them with underlying diseases including liver cirrhosis and cancer (Chi et al., 2004; Han & Andrade, 2005; Lee et al., 2011) . B. diminuta mostly causes bacteraemia, but other occasional but serious infections, such as spontaneous bacterial peritonitis and cystic fibrosis, were also reported (Chi et al., 2004; Menuet et al., 2008) . Here we present what is to our knowledge the first case of pleuritis caused by B. diminuta in the pleural fluid of a young male without immunocompromising conditions. Though he was a heavy smoker and diagnosed with mild fatty liver, he was in a healthy condition, and a variety of underlying disease screening tests were negative. In fact, M. tuberculosis was initially suspected as a pathogen, but a series of related tests remained negative, including real-time PCR, anti-acid staining, adenosine deaminase level in pleural fluid and a T-spot test, which made mycobacterial infection unlikely. B. diminuta has been isolated from water, soil and plants as an environmental organism. Accordingly, we considered whether it represented the true pathogen or not. However, contamination of our clinical samples by B. diminuta had never been observed. The database review indicated that during the past 5 years we had never isolated B. diminuta from sterile body fluids. Additionally, the strain of bacteria isolated from the two consecutive pleural fluids presented with the same AST profile, which made the presence of a contaminant in our samples unlikely. Therefore, we strongly believed that this was the causative agent for the bacterial pleuritis, which might initially cause respiratory infections and then invasive pleuritis. 
F, Female; M, male; N, not determined or not mentioned; R, resistant; S, susceptible; SBP, spontaneous bacterial peritonitis. *Seven patients were reported, comprising one female and six males. DThree patients were reported, comprising two females and one male. dNumber in parentheses represents case numbers. §Number in parentheses represents all susceptible/tested strains. Community-acquired pleuritis due to B. diminuta Lee et al. (2011) reported that Brevundimonas species were frequently misidentified by the Phoenix system. The same is true of the strain in our case, which was misidentified as K. kingae. According to our study, if its incubation period was extended to about 48 h, the correct identification was obtained as some critical biochemical tests changed from negative to positive. O'Hara (2006) documented that the Phoenix system NID panel fell short of being an acceptable method for the identification of Gram-negative isolates in clinical microbiology laboratories. In fact, this NID panel has 45 substrates for identification, read every 20 min, and its testing ceases after 12 h 20 min. Correct identification of some bacteria by conventional microbiology methods is often limited due to low biochemical reactivity, slow growth and metabolic rates, and phenotypic variation, leading to ambiguous reactions within the short incubation times (Chatzigeorgiou et al., 2011; Lee et al., 2011) . Therefore, confirmatory analyses were required before assigning identification to an organism if the Phoenix system gave a suspicious result, for a major error of misidentification would affect the interpretation of the accompanying ASTs and result in treatment failure, as occurred in our case. MALDI-TOF MS outperformed the BD Phoenix for identification of infrequently isolated Gram-negative bacilli (Saffert et al., 2011) , which might be a more reliable and versatile tool for identification of nonfermenting Gram-negative bacilli in future (Fernández-Olmos et al., 2012) . Furthermore, the results from our case and a case series from Taiwan (Lee et al., 2011) hinted at the possibility that B. diminuta infection in Chinese patients might be underdiagnosed or reported.
Although B. diminuta is capable of causing infections, it is generally non-fatal because of uniform susceptibility to aminoglycosides (e.g. gentamicin and amikacin), ticarcillin/ clavulanate, piperacillin/tazobactam and carbapenems (imipenem) as documented in previous studies (Han & Andrade, 2005; Lee et al., 2011; Menuet et al., 2008) . In fact, these antibiotics have often been proved to be effective in the treatment of the invasive infections caused by B. diminuta, as shown in Table 1 (Han & Andrade, 2005; Lee et al., 2011; Menuet et al., 2008) . However, the commonly used anti-pseudomonal agents, including anti-pseudomonal cephalosporins and fluoroquinolones, are thought to have undesirable effects, and furthermore, B. diminuta was proved to be intrinsically resistant to fluoroquinolones (Han & Andrade, 2005) , as confirmed by other studies (Lee et al., 2011; Menuet et al., 2008) . However, in a patient with bacteraemia, B. diminuta was found to be susceptible to ciprofloxacin (Chi et al., 2004) . In this sense, its susceptibility to fluoroquinolones is conflicting and requires further investigation. In our case ciprofloxacin was initially given as the isolates were misidentified as K. kingae, which was indicated as being susceptible to ciprofloxacin (Roiz et al., 1997; Yagupsky et al., 2001) , but the patient did not improve. Afterwards, the antibiotic treatment was switched to piperacillin/tazobactam and the patient recovered successfully. According to an overview of the literature and our experience, we suggest that aminoglycosides, piperacillin/tazobactam, and carbapenems are effective in treating B. diminuta infections.
